Australia markets closed

Kura Oncology Inc (KUR.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
17.55+0.67 (+3.97%)
As of 10:32AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
115,235
115,235
92,812
84,721
60,397
Selling general and administrative
50,569
50,569
47,053
46,537
31,502
Total operating expenses
165,804
165,804
139,865
131,258
91,899
Operating income or loss
-165,804
-165,804
-139,865
-131,258
-91,899
Interest expense
1,549
1,549
229
414
578
Total other income/expenses net
-
-
-
-
51
Income before tax
-152,631
-152,631
-135,840
-130,466
-89,625
Income from continuing operations
-152,631
-152,631
-135,840
-130,466
-89,625
Net income
-152,631
-152,631
-135,840
-130,466
-89,625
Net income available to common shareholders
-152,631
-152,631
-135,840
-130,466
-89,625
Basic EPS
-2.02
-2.08
-2.03
-1.97
-1.69
Diluted EPS
-2.02
-2.08
-2.03
-1.97
-1.69
Basic average shares
70,832
73,229
66,990
66,352
53,077
Diluted average shares
70,832
73,229
66,990
66,352
53,077